We are live on ! Find out more
PTCT icon

PTC Therapeutics
PTCT

132 hedge funds and large institutions have $1.47B invested in PTC Therapeutics in 2014 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 58 increasing their positions, 23 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

660% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 5

152% more repeat investments, than reductions

Existing positions increased: 58 | Existing positions reduced: 23

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

37% more capital invested

Capital invested by funds: $1.07B → $1.47B (+$395M)

33% more funds holding

Funds holding: 99 → 132 (+33)

53% less call options, than puts

Call options by funds: $1.5M | Put options by funds: $3.18M

Holders
132
Holders Change
+33
Holders Change %
+33.33%
% of All Funds
3.52%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.08%
New
38
Increased
58
Reduced
23
Closed
5
Calls
$1.5M
Puts
$3.18M
Net Calls
-$1.68M
Net Calls Change
-$1.68M

Top Buyers

Rank Fund Capital Flow
1
BB
BB Biotech
Switzerland
+$54.1M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$26.8M
3
CCI
Columbus Circle Investors
+$26.8M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$25.5M
5
CCM
Camber Capital Management
Massachusetts
+$16.1M

Top Sellers

Rank Fund Capital Flow
1
BCPEM
Bain Capital Public Equity Management
Massachusetts
-$34.3M
2
CS
Credit Suisse
Switzerland
-$16.7M
3
Millennium Management
Millennium Management
New York
-$14.1M
4
SAM
Sectoral Asset Management
Quebec, Canada
-$8.24M
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$7.7M
Name Holding Trade Value Shares
Change 		Change in
Stake
Deutsche Bank
51
Deutsche Bank
Germany
$3.76M -$2.24M -50,839 -41%
EI
52
EAM Investors
California
$3.67M +$58.1K +1,319 +2%
Axa
53
Axa
France
$3.42M +$186K +4,226 +7%
Charles Schwab
54
Charles Schwab
California
$3.39M +$315K +7,145 +12%
NFA
55
Nationwide Fund Advisors
Ohio
$3.01M +$1.26M +28,539 +96%
MSA
56
Mason Street Advisors
Wisconsin
$2.94M – – –
Ameriprise
57
Ameriprise
Minnesota
$2.89M +$941K +21,370 +62%
AQR Capital Management
58
AQR Capital Management
Connecticut
$2.71M +$426K +9,676 +23%
RFC
59
Russell Frank Company
Washington
$2.61M -$122K -2,772 -5%
RA
60
Royce & Associates
New York
$2.59M – – –
DC
61
Davenport & Co
Virginia
$2.39M – – –
California State Teachers Retirement System (CalSTRS)
62
California State Teachers Retirement System (CalSTRS)
California
$2.36M +$198K +4,493 +11%
Macquarie Group
63
Macquarie Group
Australia
$2.22M +$410K +9,307 +28%
TCM
64
Timpani Capital Management
Wisconsin
$1.85M +$1.57M +35,775 New
California Public Employees Retirement System
65
California Public Employees Retirement System
California
$1.78M +$966K +21,935 +210%
TA
66
Teachers Advisors
New York
$1.77M -$698K -15,861 -32%
AllianceBernstein
67
AllianceBernstein
Tennessee
$1.73M +$106K +2,400 +8%
Mackenzie Financial
68
Mackenzie Financial
Ontario, Canada
$1.63M +$1.39M +31,500 New
Millennium Management
69
Millennium Management
New York
$1.61M -$14.1M -320,704 -91%
Royal Bank of Canada
70
Royal Bank of Canada
Ontario, Canada
$1.56M -$725K -16,474 -35%
BIM
71
Bogle Investment Management
Massachusetts
$1.48M +$1.25M +28,494 New
ProShare Advisors
72
ProShare Advisors
Maryland
$1.42M +$140K +3,183 +13%
Neuberger Berman Group
73
Neuberger Berman Group
New York
$1.41M +$282K +6,400 +31%
HCM
74
Highbridge Capital Management
New York
$1.37M +$1.17M +26,477 New
RCM
75
RA Capital Management
Massachusetts
$1.34M – – –
1 2
3
4 5

PTCT Hedge Fund Activity: Q4 2014 in Review

132 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in PTC Therapeutics (PTCT) for Q4 2014, worth a combined $1.47B — up 37% from $1.07B a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new PTCT positions and 5 closed out — a net gain of 33 holders — while 58 added to existing stakes and 23 trimmed.

The largest buyer was BB Biotech, opening a new position worth an estimated $54.1M. The largest seller was Bain Capital Public Equity Management, cutting an estimated $34.3M.

  • 132 institutional investors held PTC Therapeutics (PTCT) as of Q4 2014, up from 99 in Q3 2014.
  • Funds reported $1.47B of PTC Therapeutics stock for Q4 2014, up 37% quarter-over-quarter.
  • 38 funds opened new PTC Therapeutics positions in Q4 2014 and 5 closed out, a net change of +33 holders.
  • The largest PTC Therapeutics buyer in Q4 2014 was BB Biotech, an estimated $54.1M added.
  • The largest PTC Therapeutics seller in Q4 2014 was Bain Capital Public Equity Management, an estimated $34.3M sold.

Based on aggregated 13F filings for Q4 2014.